Adverse Drug Reactions Advisory Committee

From WikiMD's WELLNESSPEDIA

The Adverse drug Reactions Advisory Committee or ADRAC is a subcommittee of the Australian drug Evaluation Committee (ADEC) which monitors the safety of medicines in Australia. ADRAC evaluates reports from the Adverse drug Reactions Unit of the Therapeutic Goods Administration (TGA), which administers the adverse drug reaction (ADR) reporting system in Australia, and may make recommendations regarding the medication including withdrawal of medications from the market. ADRAC also publishes the Australian Adverse drug Reactions Bulletin to raise awareness of medication safety issues and ADR reports.

This article is a stub.

You can help WikiMD by registering to expand it.
Editing is available only to registered and verified users.
WikiMD is a comprehensive, free health & wellness encyclopedia.

Stub icon

This medical article is a stub. You can help WikiMD by expanding the page.


Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Adverse_Drug_Reactions_Advisory_Committee&oldid=6497305"